State Street Corp Bio N Tech Se Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Bio N Tech Se stock. As of the latest transaction made, State Street Corp holds 155,867 shares of BNTX stock, worth $17.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,867

Previous 152,853 1.97%

Holding current value

$17.6 Million

Previous $12.3 Million 50.71%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $236,177 - $375,725	3,014 Added 1.97%	155,867 $18.5 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $916,425 - $1.17 Million	11,404 Added 8.06%	152,853 $12.3 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $822,524 - $1.04 Million	9,246 Added 6.99%	141,449 $13 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $343,639 - $426,195	3,780 Added 2.94%	132,203 $14 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $233,445 - $296,439	2,370 Added 1.88%	128,423 $14 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $142,996 - $180,746	1,394 Added 1.12%	126,053 $13.6 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $589,071 - $738,538	4,806 Added 4.01%	124,659 $15.5 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $1.57 Million - $2.47 Million	13,268 Added 12.45%	119,853 $18 Million
Q3 2022 Nov 15, 2022	BUY	$127.65 - $183.11 $339,804 - $487,438	2,662 Added 2.56%	106,585 $14.4 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $1.02 Million - $1.55 Million	-8,313 Reduced 7.41%	103,923 $15.5 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $6.96 Million - $12.8 Million	55,162 Added 96.65%	112,236 $19.1 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $1.2 Million - $2 Million	5,517 Added 10.7%	57,074 $14.7 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $8.8 Million - $19.1 Million	42,747 Added 485.21%	51,557 $14.1 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $116,832 - $248,976	1,031 Added 13.25%	8,810 $1.97 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $15,345 - $21,390	179 Added 2.36%	7,779 $849,000
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $552,596 - $984,503	7,600 New	7,600 $620,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Bio N Tech Se Transaction History